UBS Group’s Opko Health OPK Stock Holding History

UBS Group’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-500,000	Closed	-$5.29M	–	7958
2016 Q3	$5.29M	Hold	500,000	–	–	﹤0.01%	1969
2016 Q2	$4.67M	Buy	500,000 +471,400	+1,648%	+$4.79M	﹤0.01%	2000
2016 Q1	$297K	Buy	28,600 +27,900	+3,986%	+$255K	﹤0.01%	4187
2015 Q4	$7K	Hold	700	–	–	﹤0.01%	7522
2015 Q3	$6K	Sell	700 -5,000	-88%	-$66.2K	﹤0.01%	7609
2015 Q2	$92K	Hold	5,700	–	–	﹤0.01%	5467
2015 Q1	$81K	Sell	5,700 -55,300	-91%	-$720K	﹤0.01%	5601
2014 Q4	$609K	Buy	+61,000	New	+$522K	﹤0.01%	4017

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

WCM

Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

UBS Group's OPK Position: Q2 2026 in Review

UBS Group reduced its Opko Health (OPK) stake by 18% in Q2 2026, selling an estimated $1.36M and leaving 5,006,284 shares worth $7.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3766.

UBS Group first reported a position in OPK in Q4 2014 and has held it in 47 quarters since. The position peaked at $19.9M in Q3 2017. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

UBS Group held 5,006,284 shares of Opko Health worth $7.51M as of Q2 2026.
UBS Group sold 1,065,148 Opko Health shares in Q2 2026, an estimated $1.36M.
Opko Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3766 holding.
UBS Group first reported a position in Opko Health in Q4 2014 and has held it in 47 quarters since.
UBS Group's Opko Health position peaked at $19.9M in Q3 2017.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.